Small Molecules
6 March 2013
Progenics Pharmaceuticals’ Novel Small Molecule Drugs Targeting PSMA Successfully Visualize Prostate Cancer5 March 2013
NeuroDerm Announces Positive Results of a Phase I Study of ND0612 for the Treatment of Parkinson’s Disease5 March 2013
PsiOxus Therapeutics Completes Patient Enrollment for Phase II Wasting Disease Therapeutic MT-10228 February 2013
Lundbeck receives European marketing authorization for Selincro as the first therapy approved for the reduction of alcohol consumption28 February 2013
EnVivo Pharmaceuticals Announces Initiation of Phase 3 Clinical Trial Program of EVP-6124 in Schizophrenia28 February 2013
QRxPharma Resubmits MOXDUO New Drug Application to the FDA28 February 2013
Alchemia Completes Enrolment in Pivotal Phase III HA-Irinotecan Trial of Metastatic Colorectal Cancer28 February 2013
BioLineRx’s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter the Company’s Main Therapeutic Pipeline as BL-901028 February 2013
Novan’s SB204 Could Be First Topical Sebum InhibitorNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports